Sterify
Sterify is an innovative startup dedicated to developing medical devices for the treatment and prevention of bacterial infections. Its mission is to counteract antibiotic resistance by focusing on biocidal binary products that eliminate bacteria and their biofilms, preventing microorganisms from creating resistance. The company aims to improve surgical outcomes across multiple disciplines through its proprietary technology and innovative products.
Industries
Nr. of Employees
small (1-50)
Products
Mucoadhesive hydrogel for periodontal and peri‑implant pockets
Sterile, room‑temperature stable mucoadhesive polymeric hydrogel supplied in a ready‑to‑use pre‑filled syringe for application into periodontal and peri‑implant pockets. The formulation acts as a mechanical occlusive filler to limit bacterial re‑entry and provides sustained release of antimicrobial peptides, polyphenols and a vitamin C derivative to support anti‑biofilm activity and tissue regeneration. Pre‑clinical biocompatibility evaluation has been completed and a clinical investigation under EU MDR has been initiated.
Sterile 3D wound‑healing patch with sustained antimicrobial release
Preformed sterile patch for chronic or difficult wounds designed to deliver sustained release of antimicrobial peptides and polyphenols while promoting fibroblast activity and extracellular matrix production. Device is formulated for ambient stability and clinical readiness.
Aqueous anti‑biofilm prosthesis wash
Sterile aqueous solution supplied in packaging designed to contain prostheses during treatment; formulated to deliver antimicrobial peptides, polyphenols and low molecular weight polymers to enhance surface activity and inhibit biofilm formation prior to implantation.
Mucoadhesive hydrogel for periodontal and peri‑implant pockets
Sterile, room‑temperature stable mucoadhesive polymeric hydrogel supplied in a ready‑to‑use pre‑filled syringe for application into periodontal and peri‑implant pockets. The formulation acts as a mechanical occlusive filler to limit bacterial re‑entry and provides sustained release of antimicrobial peptides, polyphenols and a vitamin C derivative to support anti‑biofilm activity and tissue regeneration. Pre‑clinical biocompatibility evaluation has been completed and a clinical investigation under EU MDR has been initiated.
Sterile 3D wound‑healing patch with sustained antimicrobial release
Preformed sterile patch for chronic or difficult wounds designed to deliver sustained release of antimicrobial peptides and polyphenols while promoting fibroblast activity and extracellular matrix production. Device is formulated for ambient stability and clinical readiness.
Aqueous anti‑biofilm prosthesis wash
Sterile aqueous solution supplied in packaging designed to contain prostheses during treatment; formulated to deliver antimicrobial peptides, polyphenols and low molecular weight polymers to enhance surface activity and inhibit biofilm formation prior to implantation.
Services
Clinical and scientific validation partnerships
Coordination with external clinical opinion leaders and professional networks to run independent scientific and clinical validation studies for device performance and safety.
Regulatory and commercialization advisory for dental market entry
Regulatory planning and commercialization support prioritizing dental indications to shorten certification timelines and optimize pre‑market investment.
Manufacturing process design and outsourcing management
Design of scalable, low‑fixed‑cost production processes with selective outsourcing to validated and certified contract manufacturers and oversight of manufacturing partners.
Clinical investigation management under EU MDR
Operational management of clinical investigation activities and regulatory compliance tasks required for medical device clinical studies under EU MDR.
Clinical and scientific validation partnerships
Coordination with external clinical opinion leaders and professional networks to run independent scientific and clinical validation studies for device performance and safety.
Regulatory and commercialization advisory for dental market entry
Regulatory planning and commercialization support prioritizing dental indications to shorten certification timelines and optimize pre‑market investment.
Manufacturing process design and outsourcing management
Design of scalable, low‑fixed‑cost production processes with selective outsourcing to validated and certified contract manufacturers and oversight of manufacturing partners.
Clinical investigation management under EU MDR
Operational management of clinical investigation activities and regulatory compliance tasks required for medical device clinical studies under EU MDR.
Expertise Areas
- Periodontal and peri‑implant adjunctive therapy development
- Biomaterials and mucoadhesive hydrogel formulations
- Antimicrobial peptide (bacteriocin) formulation
- Formulation of polyphenol and vitamin C derivative adjuncts
Key Technologies
- Antimicrobial peptides (bacteriocins)
- Polyphenol actives (hydroxytyrosol)
- Vitamin C derivative (magnesium ascorbyl phosphate)
- Mucoadhesive polyvinyl hydrogel matrices